
Pavonib CT 3mg/40mg Capsule SR
Marketer
Acekinetics Healthcare Pvt Ltd
Salt Composition
Cinitapride (3mg) + Pantoprazole (40mg)
Overview Pavonib CT 3mg/40mg Capsule SR
Gastroesophageal reflux disease (GERD) and non-ulcer dyspepsia are effectively managed with Pavonib CT 3mg/40mg Sustained-Release Capsules. This medication targets acidity symptoms like heartburn, abdominal pain, and irritation, neutralizing stomach acid and facilitating gas expulsion for improved comfort. Dosage and duration for Pavonib CT 3mg/40mg SR Capsules are determined by your physician, taken on an empty stomach. Treatment adherence, as directed, is crucial to prevent symptom recurrence and condition exacerbation. Inform your doctor of all other medications you are using, as interactions are possible. Common, typically transient, side effects include abdominal pain, diarrhea, headache, and gas. Report any concerning side effects immediately. Dizziness is a potential side effect; avoid driving or activities requiring alertness until its impact is known. Alcohol consumption should be avoided due to potential dizziness exacerbation. Dietary adjustments, such as consuming cold milk and avoiding hot beverages, spicy foods, and chocolate, may enhance treatment efficacy. Prior to commencing treatment, disclose any kidney disease, pregnancy, pregnancy planning, or breastfeeding to your doctor.
Uses of Pavonib CT 3mg/40mg Capsule SR
Managing gastroesophageal reflux disease (GERD)
Major Benefits of Pavonib CT 3mg/40mg Capsule SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Pavonib CT 3mg/40mg SR Capsules. Ingest the capsule whole; do not crush, chew, or break it. Administer on an empty stomach.
Common Side effects of Pavonib CT 3mg/40mg Capsule SR:
- Headache
- Diarrhea
- Stomach pain
- Flatulence
- Dizziness
How to use Pavonib CT 3mg/40mg Capsule SR:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Pavonib CT 3mg/40mg Capsule SR whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
How Pavonib CT 3mg/40mg Capsule SR works:
Each Pavonib CT SR capsule (3mg/40mg) contains a dual medication formulation.
SAFETY ADVICE
AlcoholCAUTION
Use caution when combining alcohol and Pavonib CT 3mg/40mg SR capsules. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
Data on Pavonib CT 3mg/40mg SR Capsule use in pregnancy is absent. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Pavonib CT 3mg/40mg sustained-release capsules while breastfeeding are lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by side effects associated with taking Pavonib CT 3mg/40mg sustained-release capsules.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Pavonib CT 3mg/40mg sustained-release capsules in individuals with renal impairment. Seek medical advice.
LiverSAFE IF PRESCRIBED
The use of Pavonib CT 3mg/40mg sustained-release capsules in patients with hepatic impairment is likely safe. Current evidence indicates dose modification may not be necessary; however, physician consultation is recommended.
What if you forget to take Pavonib CT 3mg/40mg Capsule SR :
Should you forget a dose of Pavonib CT 3mg/40mg SR Capsules, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Pavonib CT 3mg/40mg Capsule SR
| Label | Value |
|---|---|
| Addictive | None. |
| Treatment Category | Digestive system |
